Literature DB >> 315450

Cold reactive antilymphocyte antibodies in neurological diseases.

R P Lisak, F Mercado, B Zweiman.   

Abstract

Cold reactive (15 degrees C) antilymphocyte antibodies were detected in the sera of 33% of patients with multiple sclerosis, 50% with Guillain-Barré syndrome, 42% with myasthenia gravis, and 38% with polymyositis. We did not detect such antibodies against autologous cells in multiple sclerosis. In multiple sclerosis there was no correlation between the presence of antilymphocytic antibodies and disease activity or duration. In patients with multiple sclerosis, myasthenia gravis, and polymyositis there was no correlation between the presence of cold reactive antilymphocyte antibodies and abnormalities of T or B cell levels.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315450      PMCID: PMC490401          DOI: 10.1136/jnnp.42.11.1054

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases.

Authors:  R P Lisak; B Zweiman
Journal:  N Engl J Med       Date:  1977-10-20       Impact factor: 91.245

2.  Lymphocytotoxic antibodies in multiple sclerosis.

Authors:  A L Schocket; H L Weiner; J Walker; K McIntosh; P F Kohler
Journal:  Clin Immunol Immunopathol       Date:  1977-01

3.  Inhibition of the mixed lymphocyte reaction by antibodies.

Authors:  J P Revillard; M Robert; H Betuel; M Latour; M Bonneau; J Brochier; J Traeger
Journal:  Transplant Proc       Date:  1972-06       Impact factor: 1.066

4.  Demonstration of specific T-lymphocyte membrane antigens associated with antibodies inhibiting the mixed leukocyte culture in man.

Authors:  P Wernet; H G Kunkel
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

5.  Inhibition of mixed leukocyte culture responses by serum and gamma-globulin fractions from certain patients with connective tissue disorders.

Authors:  R C Williams; R B Lies; R P Messner
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

6.  Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor.

Authors:  M Knowles; D Hughes; E A Caspary; E J Field
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

7.  Cytotoxins in disease. V. Various diseases.

Authors:  M Kreisler; S Naito; P I Terasaki
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

8.  Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination.

Authors:  M J Kreisler; A A Hirata; P I Terasaki
Journal:  Transplantation       Date:  1970-11       Impact factor: 4.939

9.  Thymic and peripheral blood T- and B-cell levels in myasthenia gravis.

Authors:  R P Lisak; B Zweiman; S M Phillips
Journal:  Neurology       Date:  1978-12       Impact factor: 9.910

10.  Lymphocytotoxic antibodies in family members of patients with multiple sclerosis.

Authors:  A L Schocket; H L Weiner
Journal:  Lancet       Date:  1978-03-18       Impact factor: 79.321

View more
  7 in total

Review 1.  The role of prostaglandins in altered leukocyte function in multiple sclerosis.

Authors:  P Dore-Duffy; S Y Ho; M Longo
Journal:  Springer Semin Immunopathol       Date:  1985

Review 2.  Immunological features of polymyositis/dermatomyositis.

Authors:  W M Behan; P O Behan
Journal:  Springer Semin Immunopathol       Date:  1985

Review 3.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity.

Authors:  C F Scott; L E Spitler
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

5.  Modulation of T-lymphocyte differentiation antigens: potential relevance for multiple sclerosis.

Authors:  J Antel; J J Oger; S Jackevicius; H H Kuo; B G Arnason
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

6.  Shared antigenic determinants between brain and thymus-derived lymphocytes in dogs.

Authors:  S Krakowka; A L Wallace; A Koestner
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

Review 7.  Abnormal serum factors in Guillain-Barré syndrome.

Authors:  R P Lisak; M J Brown; A J Summer
Journal:  Ital J Neurol Sci       Date:  1983-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.